Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05076942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Study acronym: GROINSS-VIII
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 27 Collaborators: 1 to 2v2 Show 1 more changeShow less
    • Collaborators: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vulvar cancer patients with SN-metastasis \> 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.
Trial Details
NCT Number NCT05076942
Lead Sponsor University Medical Center Groningen
Collaborators: Dutch Cancer Society, NRG Oncology
Conditions Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
Enrollment 157 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov